48 results on '"Welz J"'
Search Results
2. Rolle der Fertilitätserhaltenden Therapie bei Patientinnen mit Borderline-Tumoren des Ovars
3. Stellenwert der Rezidivoperation beim adulten Granulosazelltumor des Ovars
4. Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM
5. EXPerimentierfeld zur datengetRiebenen VErnetzung und DigitaliSierung in der LandwirtSchaft (EXPRESS). Experimental field for data-driven networking and digitization in agriculture (EXPRESS)
6. How are urban green spaces and residential development related? A synopsis of multi-perspective analyses for Leipzig, Germany
7. Oral contraceptive use and tamoxifen therapy are not associated with increased levels of thrombin or impaired endogenous APC formation: PA 3.17–6
8. Cavitation in Co-Rotating Tip Vortices
9. Intrauterine Therapie der fetalen CMV Infektion mit Valganciclovir, eine Falldarstellung
10. Schwangerschaft und Geburt bei uteriner arteriovenöser Malformation: ein Fallbericht
11. Tamoxifen induziert sekundäre Resistenz gegenüber aktiviertem Protein C
12. A 500 MeV-100µ,A Proton Target for the ISAC Radioactive Ion Beam Facility
13. The TRIUMF optically-pumped polarized H$^{-}$ ion source, TRI-PP-95-19, TRI-PP-95-73
14. Free-field propagation of high intensity noise
15. A Fully Integrated Quad-Band GPRS/EDGE Radio in 0.13¿m CMOS
16. A Tight Signal-Band Power Bound on Mismatch Noise in a Mismatch-Shaping Digital-to-Analog Converter
17. A 32-channel front-end for wireless HID using inverse-STF pre-filtering technique.
18. Necessary and sufficient conditions for mismatch shaping in a general class of multibit dacs
19. An audio ADC Delta-Sigma modulator with 100-dB peak SINAD and 102-dB DR using a second-order mismatch-shaping DAC
20. Simplified logic for first-order and second-order mismatch-shaping digital-to-analog converters
21. An audio ADC delta-sigma modulator with 100 dB SINAD and 102 dB DR using a second-order mismatch-shaping DAC.
22. The TRIUMF optically pumped polarized H− ion source
23. Spin-exchange polarization study at the TRIUMF OPPIS
24. 60 keV beam transport line and switch-yard for ISAC
25. Segmented mismatch-shaping D/A conversion
26. A necessary and sufficient condition for mismatch shaping in multi-bit DACs
27. The TRIUMF high-current DC optically-pumped polarized H/sup -/ ion source
28. An audio ADC delta-sigma modulator with 100 dB SINAD and 102 dB DR using a second-order mismatch-shaping DAC
29. Status of the TRIUMP-ISAC facility for accelerating radioactive beams
30. The mismatch-noise PSD from a tree-structured DAC in a second-order ΔΣ modulator with a midscale input
31. Segmented mismatch-shaping D/A conversion.
32. A necessary and sufficient condition for mismatch shaping in multi-bit DACs.
33. The mismatch-noise PSD from a tree-structured DAC in a second-order ΔΣ modulator with a midscale input.
34. A 500 MeV-100 /spl mu/A proton target for the ISAC radioactive ion beam facility.
35. The TRIUMF high-current DC optically-pumped polarized H/sup -/ ion source.
36. 60 keV beam transport line and switch-yard for ISAC.
37. Status of the TRIUMP-ISAC facility for accelerating radioactive beams.
38. Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.
39. TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer.
40. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
41. Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study.
42. Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients.
43. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
44. Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer.
45. Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience.
46. Self-reported physical, mental, and reproductive sequelae after treatment of abnormally invasive placenta: a single-center observational study.
47. Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study.
48. Tamoxifen induces resistance to activated protein C.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.